The use of contrast‐enhanced transthoracic echocardiography for spiral‐variant hypertrophic cardiomyopathy

Hypertrophic cardiomyopathy is a common heritable cardiomyopathy with various clinical phenotypes. A rare spiral variant has been recently reported that has been associated with adverse outcomes and has traditionally been diagnosed using cardiac magnetic resonance. We report a case of the rare variant spiral hypertrophic cardiomyopathy where we used transthoracic echocardiography with an ultrasound enhancing agent to demonstrate the geometry of spiral hypertrophic cardiomyopathy and compared to simultaneous cardiac MRI images. The use of echocardiography with ultrasound enhancing agents may prove to be a valuable tool in identifying the geometry of hypertrophic cardiomyopathy variants in selected patients.

[1]  R. Biederman,et al.  The Use of Contrast-Enhanced Transthoracic Echocardiography for Spiral Variant Hypertrophic Cardiomyopathy , 2020 .

[2]  B. Popescu,et al.  The role of echocardiography for diagnosis and prognostic stratification in hypertrophic cardiomyopathy , 2020, Journal of Echocardiography.

[3]  Jong-Min Song,et al.  Geometric predictors of left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy: a 3D computed tomography analysis , 2018, European heart journal cardiovascular Imaging.

[4]  B. Gersh,et al.  Hypertrophic Cardiomyopathy: Clinical Update. , 2018, JACC. Heart failure.

[5]  W. Vletter,et al.  Three-dimensional echocardiography for the assessment of left ventricular geometry and papillary muscle morphology in hypertrophic cardiomyopathy , 2018, Journal of Ultrasound.

[6]  F. Alfonso,et al.  Helical distribution of hypertrophy in patients with hypertrophic cardiomyopathy: prevalence and clinical implications , 2017, The International Journal of Cardiovascular Imaging.

[7]  N. Smedira,et al.  Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography. , 2015, Circulation. Cardiovascular imaging.

[8]  Nessim N. Amin,et al.  Spiral Hypertrophic Cardiomyopathy as Detected by Cardiac Magnetic Resonance , 2014, Echocardiography.

[9]  P. Claus,et al.  Geometric assessment of asymmetric septal hypertrophic cardiomyopathy by CMR. , 2012, JACC. Cardiovascular imaging.

[10]  N. Reichek Seeing spirals. , 2012, JACC. Cardiovascular imaging.

[11]  Barry J Maron,et al.  2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.

[12]  Vasken Dilsizian,et al.  American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: Endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomograph , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[13]  Jeroen J. Bax,et al.  Value of contrast echocardiography for left ventricular thrombus detection postinfarction and impact on antithrombotic therapy , 2009, Coronary artery disease.

[14]  W. Manning,et al.  Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. , 2009, Journal of the American College of Cardiology.

[15]  Mustafa Kurt,et al.  Impact of contrast echocardiography on evaluation of ventricular function and clinical management in a large prospective cohort. , 2009, Journal of the American College of Cardiology.

[16]  N. Reichek,et al.  Hypertrophic cardiomyopathy: cardiac magnetic resonance imaging changes the paradigm. , 2008, Journal of the American College of Cardiology.

[17]  J. Bogaert,et al.  Helical form of hypertrophic cardiomyopathy: a new entity? , 2008, European heart journal.

[18]  D. Pennell,et al.  Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. , 2003, Journal of the American College of Cardiology.

[19]  N. Nanda,et al.  Imagent Improves Endocardial Border Delineation, Inter‐reader Agreement, and the Accuracy of Segmental Wall Motion Assessment , 2003, Echocardiography.

[20]  B. Maron,et al.  Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. , 1995, Journal of the American College of Cardiology.

[21]  C. Higgins,et al.  Magnetic resonance imaging in hypertrophic cardiomyopathy. , 1985, The American journal of cardiology.

[22]  Barry J Maron,et al.  2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2011, Journal of the American College of Cardiology.